Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rink

Showing results (111-120 of 292) with videos related to

Pageof 30
Sort By:
Clinical Genitourinary Cancer|August 1, 2018
Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder CancerShoji Kimura, Francesco Soria, David D'Andrea, et al.
Urologic Oncology|June 25, 2020
The impact of cytoreductive nephrectomy on survival outcomes in patients treated with tyrosine kinase inhibitors for metastatic renal cell carcinoma in a real-world cohortFlorian Janisch, Tobias Hillemacher, Constantin Fuehner, et al.
Urologic Oncology|August 11, 2020
Primary Ta high grade bladder tumors: Determination of the risk of progressionFahad Quhal, David D'Andrea, Francesco Soria, et al.
Current Urology Reports|February 23, 2012
Biomolecular predictors of urothelial cancer behavior and treatment outcomesMichael Rink, Eugene K Cha, David Green, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2014
Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomyGeorgios Gakis, Hans-Martin Fritsche, Fahmy Hassan, et al.
Urologic Oncology|September 12, 2017
The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinomaMichael Rink, Oliver Engel, Georgios Gakis, et al.
Journal of Endourology|November 10, 2022
Which Men Do or Do Not Achieve Long-Term Symptom Relief After Holmium Laser Enucleation of the Prostate (HoLEP): 11 Years of HoLEP ExperiencePhilipp Gild, Malte W Vetterlein, Ihab Daoud, et al.
Urologic Oncology|March 27, 2020
The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC)Florian Janisch, David D'Andrea, Takehiro Iwata, et al.
Frontiers in Surgery|December 6, 2021
Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective DataFlorian Janisch, Christina Kienapfel, Constantin Fühner, et al.
World Journal of Urology|March 3, 2018
Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patientsJonas Schiffmann, Pierre I Karakiewicz, Michael Rink, et al.
Pageof 30

Showing results (111-120 of 292) with videos related to

Sort By:
Pageof 30
Clinical Genitourinary Cancer|August 1, 2018
Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder CancerShoji Kimura, Francesco Soria, David D'Andrea, et al.
Urologic Oncology|June 25, 2020
The impact of cytoreductive nephrectomy on survival outcomes in patients treated with tyrosine kinase inhibitors for metastatic renal cell carcinoma in a real-world cohortFlorian Janisch, Tobias Hillemacher, Constantin Fuehner, et al.
Urologic Oncology|August 11, 2020
Primary Ta high grade bladder tumors: Determination of the risk of progressionFahad Quhal, David D'Andrea, Francesco Soria, et al.
Current Urology Reports|February 23, 2012
Biomolecular predictors of urothelial cancer behavior and treatment outcomesMichael Rink, Eugene K Cha, David Green, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2014
Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomyGeorgios Gakis, Hans-Martin Fritsche, Fahmy Hassan, et al.
Urologic Oncology|September 12, 2017
The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinomaMichael Rink, Oliver Engel, Georgios Gakis, et al.
Journal of Endourology|November 10, 2022
Which Men Do or Do Not Achieve Long-Term Symptom Relief After Holmium Laser Enucleation of the Prostate (HoLEP): 11 Years of HoLEP ExperiencePhilipp Gild, Malte W Vetterlein, Ihab Daoud, et al.
Urologic Oncology|March 27, 2020
The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC)Florian Janisch, David D'Andrea, Takehiro Iwata, et al.
Frontiers in Surgery|December 6, 2021
Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective DataFlorian Janisch, Christina Kienapfel, Constantin Fühner, et al.
World Journal of Urology|March 3, 2018
Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patientsJonas Schiffmann, Pierre I Karakiewicz, Michael Rink, et al.
Pageof 30